Outer membrane vesicles of porphyromonas gingivalis elicit a mucosal immune response

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Nakao, Ryoma ^a   Hasegawa, Hideki ^a   Ochiai, Kuniyasu ^b   Takashiba, Shogo ^c   Ainai, Akira ^a   Ohnishi, Makoto ^a   Watanabe, Haruo ^a   Senpuku, Hidenobu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BACTERIAL ANTIGEN; DOUBLE STRANDED RNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE VESICLE; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; EPITOPE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; BACTERIAL CELL; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GALE GENE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; SALIVA; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL MEMBRANE; CROSS REACTION; CYTOLOGY; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MUCOSAL IMMUNITY; MUTATION; ULTRASTRUCTURE;

MUS; OAT MOSAIC VIRUS; PORPHYROMONAS GINGIVALIS;

ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL PROTEINS; CELL MEMBRANE; CROSS REACTIONS; FEMALE; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNODOMINANT EPITOPES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MUTATION; PORPHYROMONAS GINGIVALIS;

EID: 80054122559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026163     Document Type: Article

References (34)

1. Lamont RJ, Jenkinson HF, (1998) Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiology and molecular biology reviews: MMBR 62: 1244-1263.
2. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, et al. (2005) Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111: 576-582.
3. Ishihara K, Nabuchi A, Ito R, Miyachi K, Kuramitsu HK, et al. (2004) Correlation between detection rates of periodontopathic bacterial DNA in coronary stenotic artery plaque [corrected] and in dental plaque samples. Journal of clinical microbiology 42: 1313-1315.
4. Ojima M, Takeda M, Yoshioka H, Nomura M, Tanaka N, et al. (2005) Relationship of periodontal bacterium genotypic variations with periodontitis in type 2 diabetic patients. Diabetes care 28: 433-434.
5. Dorn BR, Dunn WA Jr, Progulske-Fox A, (1999) Invasion of human coronary artery cells by periodontal pathogens. Infection and immunity 67: 5792-5798.
6. Lalla E, Lamster IB, Feit M, Huang L, Spessot A, et al. (2000) Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. The Journal of clinical investigation 105: 1117-1124.
7. Li L, Messas E, Batista EL Jr, Levine RA, Amar S, (2002) Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105: 861-867.
8. Nikaido H, (2005) Restoring permeability barrier function to outer membrane. Chemistry & biology 12: 507-509.
9. Beveridge TJ, (1999) Structures of gram-negative cell walls and their derived membrane vesicles. Journal of bacteriology 181: 4725-4733.
10. Balsalobre C, Silvan JM, Berglund S, Mizunoe Y, Uhlin BE, et al. (2006) Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Molecular microbiology 59: 99-112.
11. Wai SN, Lindmark B, Soderblom T, Takade A, Westermark M, et al. (2003) Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115: 25-35.
12. Kouokam JC, Wai SN, Fallman M, Dobrindt U, Hacker J, et al. (2006) Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infection and immunity 74: 2022-2030.
13. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ, (2004) Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. The EMBO journal 23: 4538-4549.
14. Deslauriers M, ni Eidhin D, Lamonde L, Mouton C, (1990) SDS-PAGE analysis of protein and lipopolysaccharide of extracellular vesicules and Sarkosyl-insoluble membranes from Bacteroides gingivalis. Oral microbiology and immunology 5: 1-7.
15. Grenier D, Mayrand D, (1987) Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infection and immunity 55: 111-117.
16. Imamura T, Potempa J, Pike RN, Moore JN, Barton MH, et al. (1995) Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infection and immunity 63: 4877-4882.
17. Smalley JW, Birss AJ, (1991) Extracellular vesicle-associated and soluble trypsin-like enzyme fractions of Porphyromonas gingivalis W50. Oral microbiology and immunology 6: 202-208.
18. Haurat MF, Aduse-Opoku J, Rangarajan M, Dorobantu L, Gray MR, et al. (2011) Selective sorting of cargo proteins into bacterial membrane vesicles. The Journal of biological chemistry 286: 1269-1276.
19. Furuta N, Tsuda K, Omori H, Yoshimori T, Yoshimura F, et al. (2009) Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments. Infection and immunity 77: 4187-4196.
20. Holst J, Martin D, Arnold R, Huergo CC, Oster P, et al. (2009) Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27 (Suppl 2): B3-12.
21. Schild S, Nelson EJ, Camilli A, (2008) Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infection and immunity 76: 4554-4563.
22. Kesavalu L, Ebersole JL, Machen RL, Holt SC, (1992) Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infection and immunity 60: 1455-1464.
23. Nakao R, Senpuku H, Watanabe H, (2006) Porphyromonas gingivalis galE is involved in lipopolysaccharide O-antigen synthesis and biofilm formation. Infection and immunity 74: 6145-6153.
24. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 72: 248-254.
25. Matsumoto N, Salam MA, Watanabe H, Amagasa T, Senpuku H, (2004) Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice. Oral microbiology and immunology 19: 270-276.
26. Tsuha Y, Hanada N, Asano T, Abei T, Yamaguchi S, et al. (2004) Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity. Clinical and experimental immunology 137: 393-401.
27. Nakao R, Tashiro Y, Nomura N, Kosono S, Ochiai K, et al. (2008) Glycosylation of the OMP85 homolog of Porphyromonas gingivalis and its involvement in biofilm formation. Biochemical and biophysical research communications 365: 784-789.
28. Ichinohe T, Watanabe I, Ito S, Fujii H, Moriyama M, et al. (2005) Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. Journal of virology 79: 2910-2919.
29. Ichinohe T, Ainai A, Tashiro M, Sata T, Hasegawa H, (2009) PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Vaccine 27: 6276-6279.
30. Kuehn MJ, Kesty NC, (2005) Bacterial outer membrane vesicles and the host-pathogen interaction. Genes & development 19: 2645-2655.
31. Clinical Trials.gov. A service of the U.S. National Institutes of Health Website. Available: http://clinicaltrials.gov/ct2/show/NCT00215800. Accessed 2011 Sep 27.
32. Yamamoto S, Takeda Y, Yamamoto M, Kurazono H, Imaoka K, et al. (1997) Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. The Journal of experimental medicine 185: 1203-1210.
33. Couch RB, (2004) Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. The New England journal of medicine 350: 860-861.
34. Alaniz RC, Deatherage BL, Lara JC, Cookson BT, (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. Journal of immunology 179: 7692-7701.